Preclinical Studies

Comprehensively characterize drug activity, efficacy, and more

Submit a project inquiry

Preclinical Studies

After a lead compound has been identified and optimized, researchers can pursue a broad range of follow-up experiments to assess the drug’s activity in cells or model organisms. By comprehensively characterizing a drug and its effects, these efforts pave the way for the transition to clinical trials, in which the drug is ultimately tested on human volunteers or patients. Preclinical studies provide valuable information to ensure the safety, efficacy and deliverability of a potential therapeutic, assessing both on- and off-target activity in complex biological systems. To be most productive, this research requires thoughtful assay development, a high level of quantitative accuracy, and sophisticated bioinformatics analyses to synthesize diverse experimental data. By integrating these features into our services, we can accelerate the preclinical research process for our clients.

We can support preclinical studies through a wide range of services, including:

  • Proteomic and chemoproteomic translational studies
  • Preclinical studies across different species
  • Ex vivo target engagement analyses
  • Pharmacodynamic biomarker discovery and validation

Explore Other Phases

Our end-to-end service pipeline supports all phases of drug discovery and development.

  • Biomarker Discovery, Development & Analysis

    Identify and profile biomarkers with predictive, diagnostic, and prognostic value

  • Target Discovery & Validation

    Explore promising therapeutic targets and validate their relevance

  • Lead Generation

    Leverage high-throughput screening to discover lead compounds.

  • Lead Selection & Optimization

    Prioritize potential leads and optimize their activity

Submit a Project Inquiry

To connect with our scientific team, submit a project inquiry. Our team will be in touch shortly to schedule an introductory meeting.

Newsletter Signup

Sign up for News & Updates